Several studies reviewed by Aarsland et al. [52] also demonstrated that cholinesterase inhibitors have a positive effect on cognition and neuropsychiatric symptoms in DLB patients, including fluctuating attention, unresponsiveness, and daytime somnolence [53]. The gene discussed is BCHE; the disease is Lewy body dementia.